CAUSEWAY CAPITAL MANAGEMENT LLC - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 166 filers reported holding WUXI PHARMATECH CAYMAN INC in Q4 2014. The put-call ratio across all filers is 0.39 and the average weighting 0.4%.

Quarter-by-quarter ownership
CAUSEWAY CAPITAL MANAGEMENT LLC ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q3 2015$2,826,000
+9.9%
65,400
+5.7%
0.06%
-10.9%
Q2 2015$2,571,000
-37.2%
61,900
-41.4%
0.06%
-40.2%
Q1 2015$4,095,000
-32.7%
105,600
-41.6%
0.11%
-39.2%
Q4 2014$6,084,000
-3.9%
180,7000.0%0.18%
-19.6%
Q3 2014$6,328,000
+52.9%
180,700
+43.4%
0.22%
+29.6%
Q2 2014$4,140,000
-16.2%
126,000
-20.0%
0.17%
-23.9%
Q1 2014$4,941,000
-7.0%
157,500
+13.8%
0.22%
-26.2%
Q4 2013$5,312,000
+81.9%
138,400
+29.8%
0.30%
+26.5%
Q3 2013$2,921,000106,6000.24%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q4 2014
NameSharesValueWeighting ↓
Coupland Cardiff Asset Management LLP 449,361$15,737,00015.66%
Sloane Robinson LLP 120,000$4,202,0006.01%
Black Creek Investment Management Inc. 869,173$30,438,0003.50%
Grandeur Peak Global Advisors, LLC 358,385$12,551,0003.05%
THOMAS WHITE INTERNATIONAL LTD 538,212$18,848,0002.73%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 88,460$3,098,0001.39%
Granite Point Capital Management, L.P. 70,000$2,451,0001.22%
COMMONWEALTH BANK OF AUSTRALIA 2,626,749$91,989,0001.19%
Apex Capital Management 1,048,531$36,720,0001.11%
Pier Capital, LLC 196,369$6,877,0001.10%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders